newsfilter
← Latest News
Business Wire·

Exact Sciences Stockholders Approve Acquisition by Abbott

Exact Sciences Corporation (NASDAQ:EXAS) ("Exact Sciences"), a leading provider of cancer screening and diagnostic tests, today announced that its stockholders voted to approve the proposed acquisition of Exact Sciences